The magnificent transformation of silk materials -2023 Liangzhu Cutting edge Technology Forum: Medical silk material technology successfully concluded

Silkworm silk is the material of heaven. Silk, as a natural animal protein fiber, contains eighteen amino acids that the human body needs. Nowadays, it has surpassed the traditional function of clothing and achieved a magnificent transformation from "clothing in the past" to "medicine today" under the refinement of new technology. To further promote the vigorous development of research on medical silk materials, the 2023 Liangzhu Advanced Technology Forum: Medical Silk Material Technology was grandly held at Hangzhou Future Science and Technology City from November 24th to 26th.

This conference is an important sub event of the Hangzhou International Talent Exchange Conference and the "Yuhang International Talent Month", with the theme of "Let Silk Go to the Medical World, Let Medical Silk Go to the World", focusing on the research and development of new technologies for medical silk materials; Medical and healthcare applications of silk materials (equipment, devices, and food healthcare); Report and share the inspection, standards, supervision, and declaration of medical silk raw materials and instruments. The conference attracted numerous scholars, researchers, and business representatives from universities to attend and learn. The applause on site was continuous and the response was enthusiastic.

As the organizer of this conference, Zhejiang Xingyue Biotechnology Co., Ltd. has been focusing on the research of silk fibroin, focusing on the research and industrial transformation of silk materials in the field of regenerative medicine, achieving the integration of industry, academia, research and medical treatment, and has obtained the third type medical device registration certificate for silk raw materials. The national industry standard for medical silk materials has been approved by the national bureau, and more than 30 patents related to biomaterials have been applied for. The company has achieved fruitful scientific and technological innovation results and will further improve the efficiency of achievement transformation in the future.

Dr. Zhao Hongshi, Chief Technology Officer of Xingyue Biology and "Humboldt Scholar" of Germany, made a special report entitled "Performance Research and Application of Silk Fibroin with Different Structures" at this conference, shared from three aspects: natural silk fibroin fiber, regenerated silk fibroin membrane and regenerated silk fibroin gel, and proposed the prospect and vision of silk fibroin to open up a new "Silk Road". Dr. Zhao Hongshi's R&D team focuses on the development and application research of silk fibroin, committed to building China's medical material advantages and gradually achieving innovation and efficiency in the industry.

About the Enterprise

Xingyue Biotechnology was established at the end of 2010 and is a national high-tech enterprise created by a team of overseas returnees led by specially appointed experts and in collaboration with China Xingyue Group. The company focuses on the research and development, production, and sales of third class medical devices using silk fibroin as raw material in the fields of sports medicine and regenerative medicine. It continues to expand the application areas of silk fibroin, and with its advanced scientific research capabilities and mature experience in the industrial transformation of high-end medical biomaterials products using silk fibroin, it has entered the medical beauty industry, specializing in the subdivision of silk fibroin.